Infections Reported After Single Dose of Monkeypox Vaccine
Most of the cases of monkeypox occurring following single dose of the MVA-BN vaccine occur within 14 days.
Vaccine Information Center
Vaccine-Associated Aluminum Linked to Persistent Asthma in Young Children
Positive association seen for children with and without eczema; CDC is not changing current vaccine recommendations.
Trial Evaluating Pfizer’s Quadrivalent mRNA Influenza Vaccine Begins
The quadrivalent modRNA influenza vaccine candidate uses mRNA technology, which requires only the genetic sequence of the virus.
COVID-19 Boosters, Third Doses Well Tolerated Among Pregnant, Lactating People
Most individuals (82.8%) reported a local reaction after a COVID-19 booster or third dose, and 67.9% reported at least one systemic symptom.
New York Declares State Disaster Emergency Due to Circulating Polio Evidence
A State Disaster Emergency was declared in New York due to evidence of circulating poliovirus.
Maternal Vaccine Candidate for GBS Prevention in Infants Gets Breakthrough Tx Status
GBS6 is an investigational maternal vaccine designed to protect against the 6 most prominent GBS serotypes.
Flu Shot Recommended for All Children ≥6 Months, Early in Season
The AAP recommends annual vaccination against influenza for all children without medical contraindications, starting at age 6 months.
ACIP: Updated Vaccine Guidance for the 2022-2023 Influenza Season
In general, routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications and should be completed by the end of October.
FDA Authorizes Omicron-Adapted Booster Doses of Moderna, Pfizer-BioNTech COVID-19 Vaccines
The FDA has authorized the bivalent Moderna and Pfizer-BioNTech COVID-19 Vaccines as a single booster dose at least 2 months following the primary or booster vaccination.
Will Omicron-Specific Booster Shots Be More Effective at Combating COVID-19?
Researchers answer 5 questions about the new Omicron booster shots that may be FDA-approved for use this fall.
FDA Authorizes Use of Novavax COVID-19 Vaccine, Adjuvanted in Adolescents
The FDA has expanded the EUA for the Novavax COVID-19 Vaccine, Adjuvanted to include adolescents 12 to 17 years of age to prevent COVID-19.
Nurse-Led Interventions May Cut Children’s Fear of Needles
Divided attention and positive memory reframing are feasible and may reduce vaccine-related distress in children
UK Is First Country to Approve Moderna Omicron-Targeted Vaccine
Updated vaccine targeted to the Omicron variant is expected to have “important role” in protecting people from COVID-19 this winter
Poliovirus Discovered in NYC Wastewater
Discovery of poliovirus in sewage samples suggests there is already community transmission of the virus.
FDA Authorizes Intradermal Use of Jynneos to Increase Supply During Monkeypox Outbreak
Under the EUA, Jynneos can be administered either intradermally for individuals aged ≥18 years or subcutaneously for individuals aged <18 years.
Vaccines for Monkeypox Prevention: Jynneos and ACAM2000
An individual is considered fully vaccinated about 2 weeks after the second dose of Jynneos and 4 weeks after receiving ACAM2000.
How Can Hepatitis Vaccination Adherence Be Improved for At-Risk Adults?
Adults at risk of hepatitis A and hepatitis B have multi-dose vaccinations available, but complete and timely vaccination adherence rates are low. What can be done to encourage more vaccine adherence?
CDC: Protein-Based Novavax COVID-19 Vaccine Recommended for Adults
The Novavax COVID-19 Vaccine, Adjuvanted is administered intramuscularly as a 2-dose primary series (0.5mL each), separated by 3 weeks.
Comirnaty Gets Full FDA Approval for COVID-19 Prevention in Adolescents
The approval was based on data from a phase 3 trial which included 2260 adolescents 12 to 15 years of age enrolled in the United States.
Pfizer-BioNTech Omicron-Adapted COVID-19 Vaccine Candidates Elicit Strong Immune Response
Two Omicron-adapted Pfizer-BioNTech COVID-19 vaccine candidates elicited strong immune responses vs the current COVID-19 vaccine.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Vaccine Information Center
Loading... 
Loading...